Single- and Multiple-Dose Study to Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I Versus Linezolid in Healthy Adult Subjects

Time:2017-05-13 / View:429 times

Prev: Metabolism of MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative ring opening of 2,3-dihydropyridin-4-one catalyzed by non-P450 enzymes

Next: In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis

Back